[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work With Us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Defective Medicinal Products and Recall Management Guidance

Defective Medicinal Products and Recall Management Guidance

by Amelia Holmes | Aug 5, 2022 | Blog, MHRA

The main concerns with regard to possible defects of medicinal products and the substances used in their manufacture or packaging.

Medicinal products seized by MHRA worth just under £1,000,000

Medicinal products seized by MHRA worth just under £1,000,000

by Thomas Currie | Jul 28, 2022 | Blog, MHRA

Medicinal products seized within the week running from the 23rd-30th June, the Medicines and Healthcare products Regulatory Agency (MHRA) seized 285,000 medicines and medical devices which were valued at almost £1,000,000.

Import Licensed Human Medicine(s) to the United Kingdom (UK) – Guidance

Import Licensed Human Medicine(s) to the United Kingdom (UK) – Guidance

by Amelia Holmes | Jul 13, 2022 | Blog, MHRA, WDA(H), WDA(H)

Import Licensed Human Medicine – Prior to importation of a licensed medicine applications for the relevant Licence(s) must be completed and submitted which may include one or more of the following:

Import Unlicensed Human Medicine(s) to the United Kingdom (UK) – guidance

Import Unlicensed Human Medicine(s) to the United Kingdom (UK) – guidance

by Amelia Holmes | Jul 13, 2022 | Blog, Good Distribution Practice - GDP, MHRA, WDA(H)

An Introduced Product is an unlicensed medicine which can be imported from a country other than an approved country for import to be exported to a country other than an approved country for import, or if imported from a non-EEA country into Northern Ireland for export back to a country outside the EEA.

Termination of Licence, Authorisation or Registration

Termination of Licence, Authorisation or Registration

by Chole Greenway | Jul 1, 2022 | Blog, MHRA, WDA(H)

For the distribution of medicines and healthcare products, a licence, authorisation or registration is required depending on the type of activity.

MHRA Green Guide Update 2022

MHRA Green Guide Update 2022

by Sally Cox | May 10, 2022 | Blog, MHRA

There is a new MHRA Green Guide Update 2022 updated edition of the Rules and Guidance for Pharmaceutical Distributors called the MHRA Green Guide.

« Older Entries
Next Entries »

Recent Posts

  • RP Refresher Training
  • The MHRA’s Guide to Defective Medicinal Products – Part 2
  • The MHRA’s Guide to Defective Medicinal Products – Part 1: Overview

Upcoming Courses

  • GDP/RP Cogent Gold Standard Online Training on 17 March 2026
  • GDP/RP Cogent Gold Standard WEEKEND Training on 20 March 2026 9:30 am
  • Introduction to Good Distribution Practice Online Training on 20 March 2026 10:00 am
  • RP Forum – tbc on 7 April 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 10 April 2026 10:00 am

MHRA Alerts & Recalls

Class 2 Medicines Recall: Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml), EL(26)A/13
12 March 2026
Class 3 Medicines Recall: Bayer Plc, Various Products, EL(26)A/12
12 March 2026
Field Safety Notices: 02 to 06 March 2026
9 March 2026
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 5mg capsules, EL(26)A/11
6 March 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow